These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 15698396)

  • 1. Decreased expression of peroxisome proliferator-activated receptor alpha and liver fatty acid binding protein after partial hepatectomy of rats and mice.
    Skrtic S; Carlsson L; Ljungberg A; Lindén D; Michalik L; Wahli W; Oscarsson J
    Liver Int; 2005 Feb; 25(1):33-40. PubMed ID: 15698396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.
    Yeon JE; Choi KM; Baik SH; Kim KO; Lim HJ; Park KH; Kim JY; Park JJ; Kim JS; Bak YT; Byun KS; Lee CH
    J Gastroenterol Hepatol; 2004 Jul; 19(7):799-804. PubMed ID: 15209628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
    Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
    J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
    Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
    Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
    Oikari S; Ahtialansaari T; Huotari A; Kiehne K; Fölsch UR; Wolffram S; Jänne J; Alhonen L; Herzig KH
    Acta Physiol (Oxf); 2008 Sep; 194(1):57-65. PubMed ID: 18394026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ovariectomy on PPAR alpha, SREBP-1c, and SCD-1 gene expression in the rat liver.
    Paquette A; Wang D; Jankowski M; Gutkowska J; Lavoie JM
    Menopause; 2008; 15(6):1169-75. PubMed ID: 18665039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased peroxisome proliferator-activated receptor alpha gene expression is associated with dyslipidemia in a rat model of chronic renal failure.
    Mori Y; Hirano T; Nagashima M; Shiraishi Y; Fukui T; Adachi M
    Metabolism; 2007 Dec; 56(12):1714-8. PubMed ID: 17998026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor alpha and its response element are required but not sufficient for transcriptional activation of the mouse heart-type fatty acid binding protein gene.
    Kawabe K; Saegusa H; Seto K; Urabe H; Motojima K
    Int J Biochem Cell Biol; 2005 Jul; 37(7):1534-46. PubMed ID: 15833283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c).
    Endo M; Masaki T; Seike M; Yoshimatsu H
    Exp Biol Med (Maywood); 2007 May; 232(5):614-21. PubMed ID: 17463157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD.
    Zheng L; Lv GC; Sheng J; Yang YD
    J Gastroenterol Hepatol; 2010 Jan; 25(1):156-63. PubMed ID: 19780876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
    de Gottardi A; Pazienza V; Pugnale P; Bruttin F; Rubbia-Brandt L; Juge-Aubry CE; Meier CA; Hadengue A; Negro F
    Aliment Pharmacol Ther; 2006 Jan; 23(1):107-14. PubMed ID: 16393287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in expression levels of genes involved in fatty acid metabolism: upregulation of all three members of the PPAR family (alpha, gamma, delta) and the newly described adiponectin receptor 2, but not adiponectin receptor 1 during neonatal cardiac development of the rat.
    Steinmetz M; Quentin T; Poppe A; Paul T; Jux C
    Basic Res Cardiol; 2005 May; 100(3):263-9. PubMed ID: 15754086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6 cooperates with peroxisome proliferator-activated receptor-α-ligands to induce liver fatty acid binding protein (LFABP) up-regulation.
    Vida M; Serrano A; Romero-Cuevas M; Pavón FJ; González-Rodriguez A; Gavito AL; Cuesta AL; Valverde AM; Rodríguez de Fonseca F; Baixeras E
    Liver Int; 2013 Aug; 33(7):1019-28. PubMed ID: 23534555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
    Harano Y; Yasui K; Toyama T; Nakajima T; Mitsuyoshi H; Mimani M; Hirasawa T; Itoh Y; Okanoue T
    Liver Int; 2006 Jun; 26(5):613-20. PubMed ID: 16762007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR-alpha.
    Huang TH; Peng G; Li GQ; Yamahara J; Roufogalis BD; Li Y
    Toxicol Appl Pharmacol; 2006 Feb; 210(3):225-35. PubMed ID: 15975614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a herbal medicine on fatty liver in rats fed ethanol chronically.
    Horie Y; Kikuchi M; Yamagishi Y; Umeda R; Ebinuma H; Saito H; Kato S; Ishii H; Hibi T; Han JY
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2009 Dec; 44(6):636-48. PubMed ID: 20077758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of soy protein and isoflavone on hepatic fatty acid synthesis and oxidation and mRNA expression of uncoupling proteins and peroxisome proliferator-activated receptor gamma in adipose tissues of rats.
    Takahashi Y; Ide T
    J Nutr Biochem; 2008 Oct; 19(10):682-93. PubMed ID: 18328687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats.
    Kim MS; Wang S; Shen Z; Kochansky CJ; Strauss JR; Franklin RB; Vincent SH
    Drug Metab Dispos; 2004 Sep; 32(9):909-14. PubMed ID: 15319330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-alpha-mediated transcription of fatty acid metabolic genes.
    Huang TH; Yang Q; Harada M; Uberai J; Radford J; Li GQ; Yamahara J; Roufogalis BD; Li Y
    Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):78-85. PubMed ID: 16129467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.